Tenet Healthcare (THC) PT Lowered to $110 at Raymond James
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq rallies as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts THC Hot Sheet
Price: $271.76 +1.07%
Rating Summary:
24 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 20 | New: 13
Rating Summary:
24 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 20 | New: 13
Join SI Premium – FREE
Raymond James analyst John Ransom lowered the price target on Tenet Healthcare (NYSE: THC) to $110.00 (from $120.00) while maintaining a Strong Buy rating.
You May Also Be Interested In
- Tenet Healthcare (THC) PT Raised to $305 at Mizuho
- Tenet Healthcare (THC) PT Raised to $285 at Baird
- Avita Medical Ltd. (RCEL) PT Raised to $20 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
